The FDA Just Approved a Long-Lasting Injection to Prevent HIV
Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming infected with HIV. But big questions remain over the drug’s affordability.
Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming infected with HIV. But big questions remain over the drug’s affordability.
What's Your Reaction?
Hemanth Kumar Gorle
Mr. Hemanth Kumar Gorle, founder of Indian Web Services, specializes in web development, hosting, and online marketing. He is dedicated to creating effective digital solutions and fostering successful business relationships through his expertise and strategic approach.
